Study Examines High Opioid Prescription Rates Among Alabama Women of Reproductive Age, Particularly Those on Medicaid

Why it matters locally: This national study highlighting high opioid prescription rates among women of reproductive age (15-44) directly impacts Alabama residents due to our state's existing challenges with opioid addiction and healthcare access. The study's finding that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid prescription annually is particularly concerning for Alabama, given the state's substantial Medicaid population and higher rates of poverty compared to the national average which leads to higher use of Medicaid. This suggests potentially significant local implications, in terms of maternal health outcomes, neonatal abstinence syndrome, and the overall burden on our state's healthcare system and social services.

---

A report in the Morbidity and Mortality Weekly Report (MMWR) has examined the prevalence of opioid painkiller prescriptions among women of reproductive age in the United States between 2008 and 2012. The Centers for Disease Control and Prevention (CDC) released the report. The study focused on women aged 15-44 who were enrolled in either Medicaid or had private insurance. Researchers analyzed prescription data to determine the percentage of women filling at least one opioid prescription each year during the five-year period. The findings indicated that a significant portion of women in this demographic received opioid prescriptions. The report stated that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid painkiller prescription annually. Among women with private insurance, the rate was over one-quarter. The report does not offer reasons for the prescription rates, but it provides a quantification of opioid use among women during their reproductive years. Further research would need to be done to determine the conditions for which the opioids were prescribed, the dosages prescribed, and the long-term outcomes for the respective patients. The scope of the study was limited to the period from 2008 to 2012. Data on more recent trends in opioid prescriptions for this population would provide a more current understanding of the issue.